1 0. 3 3 8 9 / f n e u r. 2 0 1 7. 0 0 4 8 5. wegner p, elter t, et al. progression of biological markers in 37. torres - ramos y, montoya - estrada a, cisneros b, tercero - perez spinocerebellar ataxia type 3 : analysis of longitudinal data from k, leon - reyes g, leyva - garcia n, et al. oxidative stress in spithe esmi cohort. medrvix. medrxiv 2025. 01. 30. 25321426 ; doi : nocerebellar ataxia type 7 is associated with disease severity. https : / / doi. org / 10. 11 01 / 20 25. 01. 30. 25321426. cerebellum. 2018 ; 17 : 601 – 9. https : / / doi. org / 1 0. 1 0 0 7 / s 1 2 3 1 1 - 0 1 23. gaetani l, blennow k, calabresi p, di filippo m, parnetti l, 8 - 0 9 4 7 - 0. zetterberg h. neurofilament light chain as a biomarker in neuro - 38. vazquez - mojena y, rodriguez - cordova y, dominguez - barrios logical disorders. j neurol neurosurg psychiatry. 2019 ; 90 : 870 – y, leon - arcia k, miranda - becerra d, gonzalez - zaldivar y, et al. 81. https : / / doi. org / 1 0. 1 1 3 6 / j n n p - 2 0 1 8 - 3 2 0 1 0 6. peripheral inflammation links with the severity of clinical pheno24. faber j, berger m, wilke c, hubener - schmid j, schaprian t, type in spinocerebellar ataxia 2. mov disord. 2023 ; 38 : 880 – 5. h t santana mm, et al. stage - dependent biomarker changes in spi - t p s : / / d o i. o r g / 1 0. 1 0 0 2 / m d s. 2 9 3 5 9. nocerebellar ataxia type 3. ann neurol. 2024 ; 95 : 400 – 6. https : / / d39.